Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.12%ABBV-2.40%1398.HK-1.47%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.04%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.73%1288.HK-1.97%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.51%GBPTRY+0.41%NZDCHF+0.40%AUDCHF+0.40%USDCAD-0.39%EURCAD-0.33%CADJPY+0.33%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%USDTRY+0.27%EURCHF+0.27%CHFJPY-0.25%NZDSGD+0.24%AUDSGD+0.24%GBPJPY+0.24%USDNOK-0.24%NZDUSD+0.22%EURGBP-0.21%USDCHF+0.20%NZDCAD-0.20%AUDCAD-0.19%AUDUSD+0.19%NZDMXN+0.19%GBPSGD+0.19%USDZAR-0.18%NOKJPY+0.18%USDILS+0.16%USDSEK-0.16%USDPLN-0.16%EURSGD+0.16%NZDJPY+0.15%CHFSGD+0.15%CHFNOK-0.14%AUDJPY+0.14%EURNOK-0.13%GBPAUD+0.12%SGDJPY-0.11%EURNZD-0.11%EURHKD+0.11%USDDKK-0.10%EURAUD-0.10%PLNJPY+0.10%EURCNH+0.09%AUDDKK+0.08%GBPCAD-0.08%GBPNZD+0.07%EURUSD+0.07%CHFSEK-0.07%EURZAR-0.06%EURSEK-0.06%EURPLN-0.05%USDSGD+0.05%USDJPY-0.05%GBPZAR-0.05%AUDNOK-0.05%USDTHB+0.04%USDCOP-0.04%EURJPY+0.03%USDCNH-0.02%EURCZK+0.01%USDHKD+0.01%USDMXN0.00%AUDNZD0.00%EURDKK0.00%COTTON+0.74%HG1+0.66%XNGUSD+0.41%S1+0.35%W1-0.28%UKOIL-0.16%USOIL-0.11%XAUUSD+0.08%GAUUSD+0.08%XPTUSD-0.07%XAGUSD+0.07%GAGUSD+0.07%BTCUSD+2.55%ETHUSD+17.67%USDTUSD0.00%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.83%ZECUSDT+8.69%DOGEUSD+14.12%XMRUSDT+5.35%LINKUSD+13.42%XLMUSD+0.25%BCHUSDT+5.89%UNIUSD+8.15%LTCUSD+9.66%SUIUSD+3.70%HBARUSDT+0.66%TONUSD+26.15%TAOUSDT+3.71%AAVEUSD+3.45%DOTUSDT-0.03%ICPUSDT+0.40%ONDOUSDT+0.74%WLDUSDT-0.60%ARBUSDT+6.97%JUPUSDT+0.92%ATOMUSDT+1.46%INJUSDT+13.09%STXUSDT+7.49%FETUSDT+1.71%TIAUSDT+8.81%PYTHUSDT+2.44%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+4.23%IOTAUSDT+1.20%WIFUSDT+2.21%AXSUSDT-1.23%POLUSDT+3.23%FARTCOINUSDT+1.40%EOSUSDT+0.71%DYDXUSDT+4.53%GALAUSDT-1.41%ORDIUSDT+0.18%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.12%ABBV-2.40%1398.HK-1.47%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.04%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.73%1288.HK-1.97%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.51%GBPTRY+0.41%NZDCHF+0.40%AUDCHF+0.40%USDCAD-0.39%EURCAD-0.33%CADJPY+0.33%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%USDTRY+0.27%EURCHF+0.27%CHFJPY-0.25%NZDSGD+0.24%AUDSGD+0.24%GBPJPY+0.24%USDNOK-0.24%NZDUSD+0.22%EURGBP-0.21%USDCHF+0.20%NZDCAD-0.20%AUDCAD-0.19%AUDUSD+0.19%NZDMXN+0.19%GBPSGD+0.19%USDZAR-0.18%NOKJPY+0.18%USDILS+0.16%USDSEK-0.16%USDPLN-0.16%EURSGD+0.16%NZDJPY+0.15%CHFSGD+0.15%CHFNOK-0.14%AUDJPY+0.14%EURNOK-0.13%GBPAUD+0.12%SGDJPY-0.11%EURNZD-0.11%EURHKD+0.11%USDDKK-0.10%EURAUD-0.10%PLNJPY+0.10%EURCNH+0.09%AUDDKK+0.08%GBPCAD-0.08%GBPNZD+0.07%EURUSD+0.07%CHFSEK-0.07%EURZAR-0.06%EURSEK-0.06%EURPLN-0.05%USDSGD+0.05%USDJPY-0.05%GBPZAR-0.05%AUDNOK-0.05%USDTHB+0.04%USDCOP-0.04%EURJPY+0.03%USDCNH-0.02%EURCZK+0.01%USDHKD+0.01%USDMXN0.00%AUDNZD0.00%EURDKK0.00%COTTON+0.74%HG1+0.66%XNGUSD+0.41%S1+0.35%W1-0.28%UKOIL-0.16%USOIL-0.11%XAUUSD+0.08%GAUUSD+0.08%XPTUSD-0.07%XAGUSD+0.07%GAGUSD+0.07%BTCUSD+2.55%ETHUSD+17.67%USDTUSD0.00%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.83%ZECUSDT+8.69%DOGEUSD+14.12%XMRUSDT+5.35%LINKUSD+13.42%XLMUSD+0.25%BCHUSDT+5.89%UNIUSD+8.15%LTCUSD+9.66%SUIUSD+3.70%HBARUSDT+0.66%TONUSD+26.15%TAOUSDT+3.71%AAVEUSD+3.45%DOTUSDT-0.03%ICPUSDT+0.40%ONDOUSDT+0.74%WLDUSDT-0.60%ARBUSDT+6.97%JUPUSDT+0.92%ATOMUSDT+1.46%INJUSDT+13.09%STXUSDT+7.49%FETUSDT+1.71%TIAUSDT+8.81%PYTHUSDT+2.44%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+4.23%IOTAUSDT+1.20%WIFUSDT+2.21%AXSUSDT-1.23%POLUSDT+3.23%FARTCOINUSDT+1.40%EOSUSDT+0.71%DYDXUSDT+4.53%GALAUSDT-1.41%ORDIUSDT+0.18%RONINUSDT-3.42%NOTUSDT+1.21%
AN

AnaptysBio, Inc. (ANAB)

NASDAQ • Healthcare

$45.59
-$0.44 (-1.0%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$45.53
Day Range$45.16 - $46.13
Avg. Volume (3M)584.4K
Market Cap$1.3B
P/E Ratio6.8
52 Week Range
$20.18$72.36
Next EarningsIn 20 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$27.4M100%
Gross Profitminus cost of goods$30.1M110%
Operating Incomeminus R&D and overhead$66.9M244%
Net Incomeminus taxes and the rest$183.8M669%

Fundamentals & Financials

Revenue (TTM)
$237.6M
Net Income (TTM)
$195.7M
EPS (TTM)
$6.75
ROA (TTM)
61.75%
Current Ratio
5.61

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+77.5%Q1 2026$1.58
-475.0%Q2 2026-$1.84
0.0%Q3 2026$5.11
Next

Nov 3

in 20 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Met

Revenue rose 23.5% to about $27.5 million in AnaptysBio’s second fiscal quarter of 2026, reported September 21, 2026, up from roughly $22.3 million a year ago as the biotech continued advancing its antibody-based immunology programs, including partnered antibody efforts and candidates such as rosnilimab and ANB033. Operating income came in at about $14.1 million for the quarter. Consensus for the next period calls for EPS of -$0.05 on revenue of $14.8 million.

View full earnings history

About AnaptysBio, Inc.

AnaptysBio, Inc. is a biotechnology company listed on NASDAQ as ANAB that develops antibody-based medicines for autoimmune, inflammatory, and other immune-mediated diseases in the United States. FY2025 revenue was $234.6 million. Its work centers on immunology therapeutics and partnered antibody programs advanced through preclinical and clinical milestones.

Name
AnaptysBio, Inc.
CEO
Daniel Faga
Website
www.anaptysbio.com
Industry
Healthcare
Year Founded
2005
Employees
104

Today's Snapshot

AI-generated

ANAB closed 1% lower at 45.59, in line with a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level.

Trading Volume

Below 10d avg (619.6K)

401.6K

vs S&P 500 Today

Underperforming Market

-0.96%

Updated: October 13, 2026 at 20:13 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
ANAB shows clear technical weakness as price sits below most short- and medium-term moving averages and beneath the 200-day level, reinforcing the overall downbeat view. Momentum is soft with an oversold RSI near 26 yet a negative MACD and declining momentum that together signal selling pressure, while a high ADX around 40 indicates the downtrend is strong. Volatility is moderate given an ATR near $2.07, and on-balance volume trends lower, supporting the bearish bias; the classic pivot sits just above current price. Technical takeaway: Strong Sell — trend and volume favor continued weakness.
All signals
  • EMA (5 indicators)$46.73 - $53.05
    Sell
  • RSI (14)26.32
    Buy
  • Stochastic %K (14, 3, 3)11.99
    Buy
  • MACD Level (12, 26)-2.51
    Sell

Peers & Related Assets

IMVTImmunovant, Inc.
$28.71-2.6%
DNTHDianthus Therapeutics, Inc.
$77.58-4.9%
XNCRXencor, Inc.
$23.52-6.1%
ANNXAnnexon, Inc.
$3.83-3.3%
MLTXMoonLake Immunotherapeutics
ODTXOdyssey Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.